Search Ontology:

ChEBI

PI(16:0/20:4(8Z,11Z,14Z,17Z))

Term ID

CHEBI:88415

Synonyms

1-Hexadecanoyl-2-(8Z,11Z,14Z,17Z-eicosapentaenoyl)-sn-glycero-3-phospho-(1'-myo-inositol)
1-Palmitoyl-2-eicsoate
1-Palmitoyl-2-eicsoatetraenoyl-sn-glycero-3-phosphoinositol
1-Palmitoyl-2-eicsoic acid
[(2R)-3-(hexadecanoyloxy)-2-[(8Z,11Z,14Z,17Z)-icosa-8,11,14,17-tetraenoyloxy]propoxy]({[(1s,3R)-2,3,4,5,6-pentahydroxycyclohexyl]oxy})phosphinic acid
Phosphatidylinositol(16:0/20:4)
Phosphatidylinositol(16:0/20:4n3)
Phosphatidylinositol(16:0/20:4w3)
Phosphatidylinositol(36:4)
PI(16:0/20:4)
PI(16:0/20:4n3)
PI(16:0/20:4w3)
PI(36:4)
PIno(16:0/20:4)
PIno(16:0/20:4n3)
PIno(16:0/20:4w3)
PIno(36:4)

(all 17)

Definition

References

HMDB:HMDB0009790
MetaCyc:Phosphatidylinositols
PMID:20671299
Wikipedia:Lecithin

(all 4)

Ontology

ChEBI ( EBI )

Relationships

is a type of: phosphatidylinositol

phosphatidylinositol Show first 5 Terms

Phenotype

Phenotype resulting from PI(16:0/20:4(8Z,11Z,14Z,17Z))

Phenotype where environments contain PI(16:0/20:4(8Z,11Z,14Z,17Z))

Phenotype modified by environments containing PI(16:0/20:4(8Z,11Z,14Z,17Z))

Phenotype affecting PI(16:0/20:4(8Z,11Z,14Z,17Z))

Human Disease Model